IDH2 and astrocytoma (excluding glioblastoma): There were seven patients with IDH-mutant astrocytomas (range, median age: 29–49, 41 years; three males and four females), and six with IDH-mutant and 1p/19q-codeleted oligodendrogliomas (37–63, median age: 48 years; three males and three females).